Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul;13(7):e0008025.
doi: 10.1128/spectrum.00080-25. Epub 2025 May 19.

Highly carbapenem-resistant Achromobacter xylosoxidans harboring blaNDM-1 in Myanmar

Affiliations

Highly carbapenem-resistant Achromobacter xylosoxidans harboring blaNDM-1 in Myanmar

Maiko Kirikae et al. Microbiol Spectr. 2025 Jul.

Abstract

Achromobacter xylosoxidans is a multidrug-resistant, non-glucose-fermenting, gram-negative bacterium with intrinsic resistance to many antimicrobial agents. Between 2016 and 2017, five A. xylosoxidans isolates were obtained from five patients at three hospitals in Myanmar. Minimum inhibitory concentrations (MICs) against various antimicrobial agents were determined using the microdilution method. Whole genome sequencing was performed with the MiSeq and MinION platforms. Resistance genes and their surrounding structures were identified and compared. All five isolates were resistant to amikacin and aztreonam. Among them, one isolate, MyNCGM749, was resistant to imipenem and meropenem with MICs of 256 µg/mL and amikacin with MIC of >512 µg/mL but intermediate to ciprofloxacin with MIC of 2 µg/mL. The isolate carried blaNDM-1 encoding metallo-β-lactamase, blaPSE-1 encoding extended-spectrum-β-lactamase, and blaOXA-114 (encoding intrinsic -β-lactamase present in A. xylosoxidans), along with five aminoglycoside modification encoding genes including aac(6')-Ib, aph (6)-Id, aph(3'')-Ib, ant(4')-Iib, and aph(3')-VI on its chromosome. The genetic structure surrounding blaNDM-1 contained four IS91 elements identical to those found in carbapenem-resistant Pseudomonas asiatica isolates in Myanmar. This is the first report of A. xylosoxidans in Myanmar. Although A. xylosoxidans harboring blaNDM-1 has been reported in a single strain from India, its genomic details have not been previously described. This study indicates that the blaNDM-1-containing structure flanked by IS91 is spreading among gram-negative, non-glucose-fermenting bacteria in Myanmar and neighboring countries.IMPORTANCEAchromobacter species were originally environmental organisms that became opportunistic pathogens with multidrug resistance. Achromobacter xylosoxidans is associated with nosocomially acquired infections affecting multiple organ systems, including the respiratory and urinary tracts, and, less commonly, the cardiovascular and central nervous systems. To date, carbapenem-resistant A. xylosoxidans carrying carbapenemase-encoding genes has been reported in several countries, including Greece, India, Italy, Japan, Korea, Libya, and the Netherlands. In this molecular epidemiological study on A. xylosoxidans in Myanmar, we identified the genomic structure surrounding blaNDM-1, flanked by IS91. This structure may facilitate the spread of non-glucose-fermenting gram-negative bacteria, such as Achromobacter, Pseudomonas, and Stenotrophomonas species, in Asian countries.

Keywords: Achromobacter xylosoxidans; blaNDM-1; carbapenemase; multidrug resistance.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig 1
Fig 1
Genomic environments surrounding blaNDM-1 in A. xylosoxidans MyNCGM152. The genetic environment of blaNDM-1 in MyNCGM749 closely resembled those observed in clinical isolates of P. asiatica from Myanmar and an environmental isolate of S. acidaminiphila from Bangladesh. Abbreviations: orf1: gene encoding hypothetical protein, orf2: gene encoding CPBP family intramembrane glutamic endopeptidase, orf3: gene encoding ABC transporter ATP-binding protein, orf4: gene encoding hypothetical protein, orf5: gene encoding hypothetical protein, orf6: gene encoding glutathione S-transferase N-terminal domain-containing protein, orf7: gene encoding hypothetical protein, orf8: gene encoding DNA repair ATPase, orf9: gene encoding nucleotidyltransferase domain-containing protein, and orf10: gene encoding multicopper oxidase domain-containing protein.
Fig 2
Fig 2
Molecular phylogenetic tree of A. xylosoxidans strains based on whole genome sequences. The tree includes 39 strains collected from several countries, including Australia, Argentina, Canada, China, France, Germany, India, Japan, Nigeria, Oman, Russia, Serbia, Thailand, the United Kingdom, and the United States. The five strains tested in this study, obtained from Myanmar, are highlighted in gray. Asterisk (*) indicates a pair of strains with the furthest distance. Asterisks (**) indicate with the closest distance.

References

    1. Yabuuchi E, Oyama A. 1971. Achromobacter xylosoxidans n. sp. from human ear discharge. Jpn J Microbiol 15:477–481. doi: 10.1111/j.1348-0421.1971.tb00607.x - DOI - PubMed
    1. Lambiase A, Catania MR, Del Pezzo M, Rossano F, Terlizzi V, Sepe A, Raia V. 2011. Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 30:973–980. doi: 10.1007/s10096-011-1182-5 - DOI - PMC - PubMed
    1. Ahmed MS, Nistal C, Jayan R, Kuduvalli M, Anijeet HKI. 2009. Achromobacter xylosoxidans, an emerging pathogen in catheter-related infection in dialysis population causing prosthetic valve endocarditis: a case report and review of literature. Clin Nephrol 71:350–354. doi: 10.5414/cnp71350 - DOI - PubMed
    1. Aisenberg G, Rolston KV, Safdar A. 2004. Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989-2003). Cancer 101:2134–2140. doi: 10.1002/cncr.20604 - DOI - PubMed
    1. Turel O, Kavuncuoglu S, Hosaf E, Ozbek S, Aldemir E, Uygur T, Hatipoglu N, Siraneci R. 2013. Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome. Braz J Infect Dis 17:450–454. doi: 10.1016/j.bjid.2013.01.008 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources